Wallonie / Walloon Region (BE3)

Innovation Performance Group (2019) : Strong

Total population (2019) 3,643,996

Population per km² (2017) 216

Proportion population older 65 year % 18,51%

Background

Walloon is a region of Southern Belgium. The regions’ S3 priorities in Health and Well being include: Health biotechnology and medical technologies Biomarkers, Diagnostics in vitro and in vivo, innovative tools and equipment, medication administration systems, innovative therapies (cell therapy, protontherapy), IT applied to human health, medical equipment, drug discovery, innovative processes and organizational innovations. Priorities in Digital technologies and Industry 4.0 include: Smart mobility, e-health, green technologies, Internet of things, serious games, big data, open data, transmedia, 3D stereoscopic imaging, serious games, digital media, Internet and mobile content, scanning and digital archiving, motion recognition.

Membership status

Member ICPerMed? no

Mountain ? Non-mountain

Member Euregha? no

Adriatic-Ionian MacroRegion? no

InnoStars Region? no

Northern Sparsely Populated Area (NSPA)? no

PM region according EC? no

Baltic Sea MacroRegion? no

S3MedTech region? yes

Danube MacroRegion? no

S3P4PM region? no

Alpine MacroRegion? no

Regions4PM region? Not yet

ERAPerMed? no

Central Europe? no

MedTech4Europe? no

Council of European BioRegions (CEBR)? yes

1M+Genome initiative? country level member

European Regions Research & Innovation Network (ERRIN)? yes

S3ClusSport member? no

Vanguard Initiative? yes

Policy Documents

Topics covered by policies : Prediction and prevention; ICT/genomics, health, lifestyle data (infrastructure); Electronic and mobile health solutions.

NACE Personalised Medicine/Personalised Health related to Research and Innovation objectives:

C.21 - Basic pharmaceutical products and pharmaceutical preparations; Q - Human health and social work activities; M - Professional, scientific and technical activities

Scientific domain NABS Personalised Medicine/Personalised Health related to Research and Innovation: NABS06 - Industrial production and technology; NABS07 - Health; NABS09 - Education; NABS12 - General advancement of knowledge: R&D financed from General University Funds (GUF); NABS13 - General advancement of knowledge: R&D financed from other sources than GUF

Policy objective Personalised Medicine/Personalised Health related related to Research and Innovation objectives: D - Digital transformation; G - Public health & security

Policy document RIS3? Yes

Policy document PM@RIS3? Yes

Major Initiatives

Self evaluation

General perception of the implementation level of PM in the region - Low

Rate of the need for developing and implementing PM in the region - High

Rate of the need for increasing support/funding for PM activities in the region - High

Rate of the need for increasing the capacity of PM skills in the region - High

Rate of the genomics literacy of the citizens in the region

Rate of the need for increasing interregional collaboration in PM - Medium

Image attribution

By Blank map of Europe (with disputed regions).svg: maix¿?derivative work: Alphathon - This file was derived from: Blank map of Europe (with disputed regions).svg:, CC BY-SA 3.0,